NBY icon

NovaBay Pharmaceuticals
NBY

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $861K invested in NovaBay Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

55% less capital invested

Capital invested by funds: $1.9M → $861K (-$1.04M)

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$42.1K
2
+$9.33K
3
+$7K

Top Sellers

1
-$25K
2
-$18K
3
-$16.6K
4
UBS Group
UBS Group
Switzerland
-$14K
5
Renaissance Technologies
Renaissance Technologies
New York
-$8.86K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$273K
2
$101K
3
$87K
4
$62K
5
$58K
6
$50K
7
$41K
8
$39K
9
$29K
10
$29K
11
$28K
12
$14K
13
$10K
14
$10K
15
$9K
16
$7K
17
$4K
18
$4K
19
$4K
20
$2.38K
21
–
22
–